Caplin Point Laboratories, based in Chennai, has allocated between 500 and 550 crore for capital expenditures (capex).

It comprises increasing current capacity, adding production facilities to increase the product line, and achieving backward integration for most items.

The Chennai-based pharmaceutical company was founded in 1990 and initially produced a variety of ointments, lotions, and other exterior treatments.

Since then, the business has grown to include the production of pharmaceutical formulations and therapies in both generic and branded categories. Tablets, capsules, injections, liquid orals, ointments, and creams are among the company's product offerings.

Currently, Caplin Point and its subsidiary Caplin Steriles have manufacturing plants and facilities in six locations including Tamil Nadu, Puducherry and Andhra Pradesh.